Chemomab Therapeutics Ltd. Price Chart
Chemomab Therapeutics Ltd. 2QV0.MU Financial and Trading Overview
| Chemomab Therapeutics Ltd. stock price | 0.73 EUR |
| Previous Close | 1.6 EUR |
| Open | 1.58 EUR |
| Bid | 1.53 EUR x N/A |
| Ask | 1.58 EUR x N/A |
| Day's Range | 1.58 - 1.58 EUR |
| 52 Week Range | 1.33 - 3.74 EUR |
| Volume | 300 EUR |
| Avg. Volume | 21 EUR |
| Market Cap | 16.53M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.458 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
2QV0.MU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Chemomab Therapeutics Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 3.74 EUR |
| 52 Week Low | 1.33 EUR |
| 50-Day Moving Average | 1.48 EUR |
| 200-Day Moving Average | 2.02 EUR |
2QV0.MU Share Statistics
| Avg. Volume (3 month) | 21 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Chemomab Therapeutics Ltd. Stock
What is a current 2QV0.MU stock price?
Chemomab Therapeutics Ltd. 2QV0.MU stock price today per share is 0.73 EUR.
How to purchase Chemomab Therapeutics Ltd. stock?
You can buy 2QV0.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Chemomab Therapeutics Ltd.?
The stock symbol or ticker of Chemomab Therapeutics Ltd. is 2QV0.MU.
How many shares does Chemomab Therapeutics Ltd. have in circulation?
The max supply of Chemomab Therapeutics Ltd. shares is 10.46M.
What is Chemomab Therapeutics Ltd. Price to Earnings Ratio (PE Ratio)?
Chemomab Therapeutics Ltd. PE Ratio is now.
What was Chemomab Therapeutics Ltd. earnings per share over the trailing 12 months (TTM)?
Chemomab Therapeutics Ltd. EPS is -0.458 EUR over the trailing 12 months.